BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25242332)

  • 1. PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.
    Ragusa S; Cheng J; Ivanov KI; Zangger N; Ceteci F; Bernier-Latmani J; Milatos S; Joseph JM; Tercier S; Bouzourene H; Bosman FT; Letovanec I; Marra G; Gonzalez M; Cammareri P; Sansom OJ; Delorenzi M; Petrova TV
    Cell Rep; 2014 Sep; 8(6):1957-1973. PubMed ID: 25242332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
    Högström J; Heino S; Kallio P; Lähde M; Leppänen VM; Balboa D; Wiener Z; Alitalo K
    Cancer Res; 2018 Oct; 78(20):5820-5832. PubMed ID: 30154153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance.
    Wiener Z; Högström J; Hyvönen V; Band AM; Kallio P; Holopainen T; Dufva O; Haglund C; Kruuna O; Oliver G; Ben-Neriah Y; Alitalo K
    Cell Rep; 2014 Sep; 8(6):1943-1956. PubMed ID: 25242330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer.
    Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
    Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
    Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prox1 is essential for oligodendrocyte survival and regulates oligodendrocyte apoptosis via the regulation of NOXA.
    Chang W; Teng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):709-717. PubMed ID: 29931031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
    Nguyen-Vu T; Wang J; Mesmar F; Mukhopadhyay S; Saxena A; McCollum CW; Gustafsson JÅ; Bondesson M; Williams C
    Oncotarget; 2016 Jul; 7(27):42159-42171. PubMed ID: 27283988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospero-related homeobox 1 gene (Prox1) is regulated by canonical Wnt signaling and has a stage-specific role in adult hippocampal neurogenesis.
    Karalay O; Doberauer K; Vadodaria KC; Knobloch M; Berti L; Miquelajauregui A; Schwark M; Jagasia R; Taketo MM; Tarabykin V; Lie DC; Jessberger S
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5807-12. PubMed ID: 21436036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
    Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
    Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK.
    Zhu L; Tian Q; Gao H; Wu K; Wang B; Ge G; Jiang S; Wang K; Zhou C; He J; Liu P; Ren Y; Wang B
    Int J Biol Sci; 2022; 18(5):2032-2046. PubMed ID: 35342346
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
    Petrova TV; Nykänen A; Norrmén C; Ivanov KI; Andersson LC; Haglund C; Puolakkainen P; Wempe F; von Melchner H; Gradwohl G; Vanharanta S; Aaltonen LA; Saharinen J; Gentile M; Clarke A; Taipale J; Oliver G; Alitalo K
    Cancer Cell; 2008 May; 13(5):407-19. PubMed ID: 18455124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary Wnt Sources Regulate Lymphatic Vascular Development via PROX1-Dependent Wnt/β-Catenin Signaling.
    Cha B; Geng X; Mahamud MR; Zhang JY; Chen L; Kim W; Jho EH; Kim Y; Choi D; Dixon JB; Chen H; Hong YK; Olson L; Kim TH; Merrill BJ; Davis MJ; Srinivasan RS
    Cell Rep; 2018 Oct; 25(3):571-584.e5. PubMed ID: 30332639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
    Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
    Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
    Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
    Chai WX; Sun LG; Dai FH; Shao HS; Zheng NG; Cai HY
    Pathol Res Pract; 2019 Oct; 215(10):152593. PubMed ID: 31471104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
    Seth C; Ruiz i Altaba A
    PLoS One; 2016; 11(3):e0150697. PubMed ID: 26939070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.